In one cohort, immunodeficient NOD-SCID mice were used as host controls, while another group of mice represented APP/PS1-21 mice (Radde et al., 2006) crossed with NOD-SCID mice (Shultz et al., 1995) to generate immunodeficient AD mice with Aβ pathology. This evidence concerns the gene APP and Alzheimer disease.